Search results for "DOPAMINERGIC"

showing 10 items of 200 documents

Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists

2011

Rationale Impulsivity is associated with a number of psychiatric disorders, most notably attention deficit/hyperactivity disorder (ADHD). Drugs that augment catecholamine function (e.g. methylphenidate and the selective noradrenaline reuptake inhibitor atomoxetine) have clinical efficacy in ADHD, but their precise mechanism of action is unclear. Objective The objective of this study is to investigate the relative contribution of dopamine (DA) and noradrenaline (NA) to the therapeutic effects of clinically effective drugs in ADHD using rats selected for high impulsivity on the five-choice serial reaction time task (5CSRTT). Methods We examined the effects of direct and indirect DA and NA rec…

MaleImpulsivityQuinpiroleDopamineSerial LearningAtomoxetine HydrochlorideImpulsivityChoice BehaviorPiperazines03 medical and health sciences0302 clinical medicineQuinpiroleDopaminemental disordersAnimals Outbred StrainsReaction TimemedicineAnimalsAttentionOriginal InvestigationPharmacologyPropylaminesMethylphenidateDopaminergicAtomoxetineGBR-12909Adrenergic AgonistsGuanfacineRats030227 psychiatry3. Good healthGuanfacineSumaniroleFive-choice serial reaction time taskAtomoxetine; Dopamine; Five-choice serial reaction time task; GBR-12909; Guanfacine; Impulsivity; Methylphenidate; Noradrenaline; Quinpirole; Sumanirole; Adrenergic Agonists; Animals; Animals Outbred Strains; Atomoxetine Hydrochloride; Attention; Benzimidazoles; Choice Behavior; Dopamine Agonists; Guanfacine; Impulsive Behavior; Male; Methylphenidate; Piperazines; Propylamines; Quinpirole; Rats; Reaction Time; Serial Learning; PharmacologyAnesthesiaDopamine AgonistsImpulsive BehaviorNoradrenalineAtomoxetineMethylphenidateBenzimidazolesmedicine.symptomPsychologyNeuroscience030217 neurology & neurosurgerymedicine.drugAtomoxetine hydrochloride
researchProduct

Involvement of Nitric Oxide in Nigrostriatal Dopaminergic System Degeneration : A Neurochemical Study.

2009

The present study was undertaken to explore the involvement of nitric oxide (NO) in the 6-hydroxydopamine (6-OHDA) experimental model of Parkinson's disease (PD) in rats. The effect of pharmacological manipulation of the NO system was evaluated on striatal dopamine (DA) level decrease produced by the toxin. 7-nitroindazole (7-NI, 50 mg/kg i.p.; n= 5) pretreatment significantly restored the striatal DA contents. Conversely, 40 mg/kg i.p. of molsidomine (MOL, n= 5), an NO donor, significantly worsened the neurodegeneration (n= 5) and completely counteracted the neuroprotective effect of 7-NI (n= 5). Thus, a crucial role for NO in 6-OHDA induced neurodegeneration is suggested together with a p…

MaleIndazolesMolsidomineParkinson's disease (PD)Substantia nigraPharmacologyNitric OxideNeuroprotectionSettore BIO/09 - FisiologiaGeneral Biochemistry Genetics and Molecular BiologyNitric oxideRats Sprague-Dawleychemistry.chemical_compoundNeurochemicalHistory and Philosophy of ScienceDopaminemedicineAnimalsNitric Oxide DonorsOxidopaminenitric oxide (NO)corpus striatumGeneral Neurosciencesubstantia nigra pars compacta (SNc)Dopaminergic6-hydroxydopamine (6-OHDA)Parkinson DiseaseRatsSubstantia NigrachemistryMolsidomineNeuroscienceOxidopaminemedicine.drug
researchProduct

Involvement of Dopamine D2 Receptors in Addictive-Like Behaviour for Acetaldehyde

2014

Acetaldehyde, the first metabolite of ethanol, is active in the central nervous system, where it exerts motivational properties. Acetaldehyde is able to induce drinking behaviour in operant-conflict paradigms that resemble the core features of the addictive phenotype: drug-intake acquisition and maintenance, drug-seeking, relapse and drug use despite negative consequences. Since acetaldehyde directly stimulates dopamine neuronal firing in the mesolimbic system, the aim of this study was the investigation of dopamine D2-receptors' role in the onset of the operant drinking behaviour for acetaldehyde in different functional stages, by the administration of two different D2-receptor agonists, q…

MaleIndoleslcsh:MedicinePharmacologyBehavioral Neurosciencechemistry.chemical_compoundquinpiroleMedicine and Health Scienceslcsh:ScienceNeuropharmacologyDrug DependenceMultidisciplinaryDopaminergicD2 dopamine receptorsAcetaldehyde; Operant self-administration; D2 dopamine receptors; quinpiroleNeurologyBehavioral PharmacologyDopamine AgonistsSignal TransductionResearch Articlemedicine.drugAlcohol DrinkingDrug-Seeking BehaviorAcetaldehydeAddictive-Like BehaviourNeuropharmacologyQuinpiroleDopamineDopamine receptor D2medicineAnimalsRats WistarAcetaldehyde; Addictive-Like Behaviour; Dopamine D2 ReceptorsPharmacologyOperant self-administrationEthanolReceptors Dopamine D2Neurotransmissionlcsh:RAcetaldehydeBiology and Life SciencesDopamine D2 ReceptorsRatsRopinirolePharmacodynamicschemistrySettore BIO/14 - FarmacologiaConditioning Operantlcsh:QNeurosciencePLoS ONE
researchProduct

PBX1 acts as terminal selector for olfactory bulb dopaminergic neurons

2020

15 páginas, 8 figuras. Supplementary information available online at http://dev.biologists.org/lookup/doi/10.1242/dev.186841.supplemental

MaleInterneuronCell SurvivalNeurogenesisRNA SplicingNeuron differentiationMitosisBiologyAdult neurogenesis03 medical and health sciencesOlfactory bulb0302 clinical medicineNeuroblastInterneuronsmedicineAnimalsProtein IsoformsCell LineageProgenitor cellTerminal selector10. No inequalityMolecular BiologyTranscription factorBody Patterning030304 developmental biologyMice KnockoutDopaminergic neuron0303 health sciencesDopaminergic NeuronsPre-B-Cell Leukemia Transcription Factor 1fungiNeurogenesisDopaminergicCell DifferentiationExonsEmbryo Mammalian3. Good healthOlfactory bulbmedicine.anatomical_structureMutationNeuron differentiationNeuroscience030217 neurology & neurosurgeryTranscription FactorsAlternative splicingDevelopmental BiologyDevelopment
researchProduct

Reduction of Dopamine Level Enhances the Attractiveness of Male Drosophila to Other Males

2009

1932-6203 (Electronic); Dopamine is an important neuromodulator in animals and its roles in mammalian sexual behavior are extensively studied. Drosophila as a useful model system is widely used in many fields of biological studies. It has been reported that dopamine reduction can affect female receptivity in Drosophila and leave male-female courtship behavior unaffected. Here, we used genetic and pharmacological approaches to decrease the dopamine level in dopaminergic cells in Drosophila, and investigated the consequence of this manipulation on male homosexual courtship behavior. We find that reduction of dopamine level can induce Drosophila male-male courtship behavior, and that this beha…

MaleLevodopaanimal structuresDopaminemedia_common.quotation_subjectlcsh:MedicineNeuroscience/Neural HomeostasisCourtshipSexual Behavior Animal03 medical and health sciences0302 clinical medicineDopamineDopaminergic CellmedicineAnimalsHomosexuality Malelcsh:ScienceDrosophila030304 developmental biologymedia_common0303 health sciencesNeuroscience/Behavioral NeuroscienceMultidisciplinaryCourtship displaybiologyNeuroscience/Sensory Systemslcsh:RfungiCourtshipbiology.organism_classificationSex pheromonebehavior and behavior mechanismsDrosophilalcsh:QDrosophila melanogasterNeuroscience030217 neurology & neurosurgeryResearch Articlemedicine.drug
researchProduct

NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference.

2004

The effects of dopaminergic and glutamatergic antagonists on the drug-induced reinstatement of a previously extinguished morphine conditioned place preference (CPP) in mice were evaluated. Following extinction of a place preference induced by morphine (40 mg/kg), a non-contingent injection of the dopaminergic antagonists SCH 23390 (0.125, 0.5 mg/kg), raclopride (0.3, 1.2 mg/kg), haloperidol (0.1, 0.2 mg/kg) and the dopamine (DA) release inhibitor CGS 10746B (1, 10 mg/kg) or glutamatergic NMDA antagonists memantine (10, 20, 40 mg/kg) and MK-801 (0.1, 0.2, 0.3 mg/kg) alone or with 10 mg/kg morphine was given. Neither the dopaminergic nor the glutamatergic antagonists alone reinstated the plac…

MaleMice Inbred StrainsPharmacologyReceptors N-Methyl-D-AspartateExtinction PsychologicalGlutamatergicMiceDopaminemedicineHaloperidolAnimalsDrug InteractionsRacloprideAnalysis of VarianceBehavior AnimalDose-Response Relationship DrugMorphineChemistryGeneral NeuroscienceDopaminergicMemantineConditioned place preferenceAnalgesics OpioidNMDA receptorConditioning OperantDopamine AntagonistsExcitatory Amino Acid Antagonistsmedicine.drugBrain research bulletin
researchProduct

7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study.

2007

The neuropathological hallmark of Parkinson's disease (PD) is the selective degeneration of dopaminergic (DAergic) neurons in the substantia nigra pars compacta (SNc). In this study, using a microdialysis technique, we investigated whether an inhibitor of neuronal nitric oxide synthase (nNOS), 7-nitrindazole (7-NI), could protect against DAergic neuronal damage induced by in vivo infusion of 1-methyl-4-phenylpiridinium iodide (MPP(+)) in freely moving rats. Experiments were performed over 2 days in three groups of rats: (a) nonlesioned, (b) MPP(+)-lesioned, and (c) 7-NI pretreated MPP(+)-lesioned rats. On day 1, control rats were perfused with an artificial CSF, while 1 mM MPP(+) was infuse…

MaleMicrodialysis1-Methyl-4-phenylpyridinium7-NitroindazoleIndazolesDopamineMicrodialysisSubstantia nigraStriatumNitric Oxide Synthase Type IPharmacologyNeuroprotectionGeneral Biochemistry Genetics and Molecular BiologyRats Sprague-Dawleychemistry.chemical_compoundHistory and Philosophy of SciencemedicineAnimalsEnzyme InhibitorsNeuronsPars compactaChemistryGeneral NeuroscienceDopaminergicNeurotoxicityParkinson Diseasemedicine.diseaseRatsSubstantia NigraDisease Models AnimalNeuroprotective Agentsnervous systemNeuroscienceAnnals of the New York Academy of Sciences
researchProduct

Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study.

2006

The effect of aspirin on dopaminergic neuronal damage induced by in vivo infusion of 1-methyl-4-phenylpiridinium iodide (MPP(+)) and 6-hydroxydopamine (6-OHDA) was studied in rats, using microdialysis. Rat striata were perfused with 1 mM MPP(+) or 6-OHDA for 10 min, causing peak levels of dopamine (DA) in the dialytic fluid, after 40 min. After 24 h, 1 mM MPP(+) was perfused again for 10 min and DA levels measured in the dialytic fluid, as an index of neuronal cell integrity. Pretreatment with Aspidol (lysine acetylsalicylate), 180 mg/kg i.p., 1 h before MPP(+) or 6-OHDA perfusion, did not modify DA extracellular output, on day 1, but restored MPP(+)-induced DA release on day 2, indicating …

MaleMicrodialysisTyrosine 3-MonooxygenaseDopamineMicrodialysisNeurotoxinsPharmacologyNeuroprotectionSettore BIO/09 - FisiologiaRats Sprague-Dawleychemistry.chemical_compoundIn vivoHydroxybenzoatesNeurotoxinAnimalsDrug InteractionsMolecular BiologyChromatography High Pressure LiquidNeuronsAnalysis of VarianceAspirinGeneral NeuroscienceMPTPDopaminergicImmunohistochemistryCorpus StriatumRatsNeuroprotective Agentsnervous systemchemistryAnesthesiaNerve DegenerationNeurology (clinical)Aspirin in vivo microdialysisPerfusionOxidopamineDevelopmental Biology
researchProduct

Influence of the amount of food ingested on mesolimbic dopaminergic system activity: a microdialysis study.

1996

Abstract The mesolimbic dopaminergic system (MDS) has been shown to be activated by ingestive behaviors, and it has been suggested that this activation may be related to the rewarding properties of foods. Because rats eat more when given a more palatable diet, this study was undertaken to determine the relationship between the amount of food ingested and DA release in the nucleus accumbens of freely moving rats. The extracellular levels of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were measured by high-performance liquid chromatography with electrochemical detection on microdialysis samples from the nucleus accumbens. Each rat underwent three microdia…

MaleMicrodialysismedicine.medical_specialtyDopamineMicrodialysisClinical BiochemistryNucleus accumbensBiologyToxicologyBiochemistryNucleus AccumbensRats Sprague-DawleyBehavioral Neurosciencechemistry.chemical_compoundEatingDopamineInternal medicinemedicineLimbic SystemAnimalsPalatabilityBiological PsychiatryPharmacologydigestive oral and skin physiologyHomovanillic acidDopaminergicHomovanillic Acidmedicine.diseaseRatsEndocrinologychemistryCatecholamine34-Dihydroxyphenylacetic AcidExtracellular SpaceIngestive behaviorsmedicine.drugPharmacology, biochemistry, and behavior
researchProduct

Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity …

2009

International audience; Three series of 1-substituted-7-chloro-6-hydroxy-tetrahydroisoquinolines (1-butyl-, 1-phenyl- and 1-benzyl derivatives) were prepared to explore the influence of each of these groups at the 1-position on the affinity for dopamine receptors. All the compounds displayed affinity for D(1)-like and/or D(2)-like dopamine receptors in striatal membranes, and were unable to inhibit [(3)H]-dopamine uptake in striatal synaptosomes. Different structure requirements have been observed for adequate D(1) or D(2) affinities. This paper details the synthesis, structural elucidation, dopaminergic binding assays, structure-activity relationships (SAR) of these three series of isoquin…

MaleModels MolecularStereochemistryDopamineClinical BiochemistryPharmaceutical ScienceMotor Activity010402 general chemistryLigands01 natural sciencesBiochemistryReceptors Dopaminechemistry.chemical_compoundMiceStructure-Activity RelationshipDopamineTetrahydroisoquinolinesDrug DiscoverymedicineStructure–activity relationshipAnimalsReceptorMolecular Biology010405 organic chemistryTetrahydroisoquinolineReceptors Dopamine D2Receptors Dopamine D1[SCCO.NEUR]Cognitive science/NeuroscienceOrganic ChemistryDopaminergicAntagonistAntidepressive AgentsCorpus Striatum3. Good health0104 chemical sciencesRatschemistryDopamine receptorHydroxyquinolinesMolecular MedicineLead compoundmedicine.drugProtein Binding
researchProduct